Technical Intelligence & Insights
Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on C Acid. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Patent CN112341512A details a novel route converting seal cholic acid to chenodeoxycholic acid, offering cost reduction in pharmaceutical intermediate manufacturing and enhanced supply reliability.
Patent CN104672114A details a green synthesis route for Furosemide intermediates offering high purity and reduced environmental impact for reliable supply chains.
Patent CN118324683A reveals a high-yield route for Cefpirome intermediates, offering significant cost reduction and supply chain reliability for pharmaceutical manufacturers.
Patent CN116286761A reveals novel aldolase screening for 4-hydroxy-2-ketobutyric acid synthesis. Enables cost-effective, scalable biomanufacturing of key pharmaceutical intermediates.
Patent CN113185476B reveals gallic acid catalysis for catechol thioethers. Offers cost reduction and scalable supply chain solutions for pharmaceutical intermediates manufacturing.
Patent CN105916864B reveals high-yield photodimerization for CBDA derivatives, offering cost reduction and supply chain reliability for electronic chemical manufacturing.
Novel adduct crystallization process for furandicarboxylic acid purification ensures supply chain stability and cost reduction in polymer monomer manufacturing.
Patent CN118685468A reveals a novel enzymatic route for high-purity chiral amino alcohol production, offering significant cost and supply chain advantages for pharmaceutical manufacturers.
Patent CN103319347A details a green electrosynthesis route for 3-methyl-4-nitrobenzoic acid, offering high purity and reduced environmental impact for supply chains.
Novel Suzuki-first synthesis route for Alzheimer's API intermediates. High yield, scalable process eliminating toxic CCl4 and chromatography.
Patent CN114426977A reveals a novel recombinant E. coli strain for D-pantolactone production, offering superior ee values and eliminating chemical waste for reliable pharmaceutical intermediate supply.
Patent CN104817589A reveals a novel Pd-catalyzed route for high-purity dialkyl phosphinic acid. Achieve significant cost reduction and supply chain reliability.
Discover the advanced polyiodide resin catalysis method for high-purity 3-O-alkyl-ascorbic acid. Enhance stability and reduce manufacturing costs for pharmaceutical intermediates.
Patent CN101300219B reveals a catalytic method for acid chloride preparation, offering significant yield improvements and reduced reaction times for pharmaceutical manufacturing.
Patent CN121159538A reveals a novel folic acid synthesis route optimizing imine intermediates for higher purity and cost reduction in vitamin manufacturing supply chains.
Patent CN101244994B details a safe, high-yield route for 2,4,5-trifluorophenylacetic acid via Willgerodt-Kindler reaction, offering significant cost and safety advantages for Sitagliptin production.
Patent CN104745550B enables high-purity statin intermediate production with mild conditions, offering significant cost reduction and supply chain reliability for global pharmaceutical manufacturers.
Patent CN105085163A reveals a novel gas-phase catalytic route for high-purity OLED material. This method ensures substantial cost savings and supply chain reliability.
Patent CN102557947A reveals a high-yield, one-step synthesis for 5-bromoacetylsalicylic acid methyl ester, offering significant cost reduction and supply chain reliability for pharmaceutical intermediates.
Patent CN109665958B details a green ruthenium-catalyzed route to polysubstituted 1-naphthoic acids using air oxidation, offering significant cost and supply chain advantages for pharmaceutical intermediates.